Analyst Report: BA

1. EXECUTIVE SUMMARY

Boeing fell 13.07% over the week to a close of $167.14 on 28 October, and nearly all of the damage came in one session. On Tuesday 27 October, after the third-quarter report and call, the shares dropped 10.69% to $168.18 on volume of 47,270,800. Management said it will miss its 737 production and delivery targets this year, pushed the 737 rate step-up into 2027, and guided free cash flow of about $3bn for 2027 against a consensus of $5.5bn (Reuters, via The Standard). Wednesday added a further 0.62% decline and a new 52-week low of $165.01 as analysts cut price targets. Defense revenue grew and backlog reached a record, but the commercial aircraft loss and the cash flow guidance drove the sell-off. The S&P 500 fell 0.17% over the same period and peers were mostly higher, so the weakness is specific to Boeing.

2. THE CATALYST

The catalyst broke on Tuesday 27 October with the third-quarter results and call. The session's close of $168.18 followed a close of $188.31 the day before.

• Production and deliveries: The CEO said Boeing will miss its 737 production and delivery targets this year and will not reach its 500-jet delivery goal (The Standard/Reuters; The Globe and Mail). Reuters reported that the 47-per-month rate is now expected in early 2027, where executives had said in May it would arrive by summer. The move to 52 a month is now targeted for the second half of 2027 (The Private Banker).
• Cash flow: Boeing guided free cash flow of about $2bn for 2026 and about $3bn for 2027, which includes $1bn of additional capital expenditure (Motley Fool transcript). Consensus for 2027 was $5.5bn per LSEG data (Reuters). The $10bn annual free cash flow target moved to 2029, one year later than before (GuruFocus).
• Quarterly results: The core loss was $0.34 a share against an LSEG estimate of a $0.21 loss (CNBC). Commercial Airplanes lost $697m at the operating line, a margin of -6.5% on revenue of $10.72bn (The Private Banker). Other sources cite loss estimates from $0.20 to $0.25, so the size of the miss varies by data provider.
• Offsets: Free cash flow was positive at $464m after roughly $700m of DOJ settlement payments (247Wallst). Revenue was $24.2bn, close to expectations in the sources checked, and backlog reached a record $745bn (Boeing press release).

Reports differ on how rare the fall was: Reuters called it the worst day in more than 18 months, while EBC called it the steepest since June 2020.

The session on 28 October brought follow-through of 0.62% on volume of 20,968,900, as multiple brokers cut targets (Stocktwits). The 2.46% fall on 22 October has no cause in the research, and 26 October was flat.

3. COMPANY PROFILE

Boeing designs, makes and supports commercial jetliners, military aircraft, satellites, missile defense and space systems. It reports through three segments: Commercial Airplanes, Defense, Space & Security, and Global Services. Airbus is the main commercial competitor, and the defense peers in the panel include Lockheed Martin, Northrop Grumman and RTX.

Recent developments from the brief:

Boeing was also picked for the Navy's F/A-XX fighter (Boeing 8-K exhibit). MarketBeat reported that buybacks were paused, a single-source claim.

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The 10-Q states that the delay in future rate increases is adversely affecting the company's financial position, results of operations and cash flows. The 2027 free cash flow guide sits well below consensus, and the 2029 target moved out a year. The market value of $132.45bn and a forward P/E of 53.9 against a trailing P/E of 17.4 show earnings expectations that remain depressed. Revenue and backlog held up, so the sell-off is about the timing of cash, which a company with $45.9bn of debt can ill afford to see slip.

Analyst response. Every cut in the brief kept the rating in place:

All targets sit above the $167.14 close, and the lowest, Morgan Stanley's $195, is 16.7% higher. UBS cut 2027 to 2030 free cash flow per share estimates by an average of 40% and called it a timing shift, with normalized free cash flow margins in the low-to-mid teens in the 2030s. BofA said the turnaround is "still intact". RBC's headline, which I did not read in full, suggests the shares may stay range-bound while the outlook is de-risked.

Comparable episodes. In January 2016 Boeing's production cut and weak earnings forecast sent shares down as much as 10% (Reuters via Business Standard). A 2021 787 delivery halt took 4.3% off the shares over a week (Benzinga). The October 2026 drop is larger than both.

Peer read-across. The brief found no sourced explanation for peer moves. Over the same period LMT rose 14.19%, HONA 8.97%, NOC 2.50%, RTX 2.21% and GE 1.77%, while HWM fell 6.23%. Only HWM moved in the same direction as Boeing, so the sell-off is company-specific.

Bull case. The record backlog, the 737-7 and 737-10 certifications, defense growth and the F/A-XX award support the recovery story. Brokers describe the reset as a delay, and the new targets look more achievable (JPMorgan's Seth Seifman).

Bear case. The 737 rate has slipped again after executives had said in May it would arrive by summer, so confidence in the schedule has taken a second hit. Debt of $45.9bn limits room for further slippage, and the 2029 target depends on 737 rates of 52 to 58 a month and 787 rates of 12 (Motley Fool transcript).

5. TECHNICAL SNAPSHOT

The $167.14 close sits below the 50-day average of $197.99 and the 200-day average of $217.70, and 34.3% below the 52-week high of $254.35 set on 27 January. The 52-week low of $165.01 was set intraday on 28 October, so the stock trades near the bottom of its range. Volume of 47,270,800 on 27 October and 20,968,900 on 28 October compares with a 50-session average of 7,865,960, and the second session ran at 2.67x that average. The latest close is the lowest in the daily table, so no nearby support level exists in that table; the $165.01 intraday low is the reference point. The nearest resistance is the $168.18 close from 27 October, followed by the $187.55 close on 22 October.

6. RISK FACTORS

• Further 737 rate slippage, since the schedule has already moved twice.
• The 2027 free cash flow guide of about $3bn leaves little cushion against $45.9bn of debt.
• Regulatory progress, including FAA movement on 777X certification, which investors are watching (FX Leaders).
• Monthly 737 and 787 delivery data, which will show whether production is tracking guidance.
• Airbus earnings, which investors are also watching (FX Leaders).
• The analyst consensus targets in circulation (an average of $267.22 from 29 analysts) predate the cuts, so published averages overstate current expectations.

Dated catalyst: Next earnings on 26 January 2027, with an EPS estimate of -$0.65 and a revenue estimate of $25.79bn.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks): The stock trades near its low after a one-day fall of 10.69% and a second session of follow-through. Further target cuts would keep pressure on the shares, while a hold above $165.01 would mark a base. Inference: after volume of this size, the price may stay between the low and the $168.18 to $187.55 area while the analyst revisions settle.

Medium term (1-3 months): Monthly delivery numbers carry the most weight, since they test the revised 737 timeline. Evidence of steady output toward 47 a month would help the shares, and further delays would push them lower. The 26 January earnings report falls just outside this window.

Long term: The thesis has shifted in timing. Free cash flow of $10bn now arrives in 2029, a year later, and brokers still back the recovery. The case rests on the 737 reaching 52 a month in the second half of 2027, and execution against that date decides whether the thesis holds. This is analysis only and not personal financial advice.